RE: Management seems uninterested in supporting sp3 Oct 2024 20:24
"Cash runway into 2026". Yes, but what then Donny? By all means think that they'll have partnerships and sales such that they won't need to raise again, but I disagree. I reckon there will be more dilution, not right now but sooner than you think. When they say "cash runway into 2026", you can be sure it'll be done and dusted by the end of calendar 2025.
How many pre-profitable biotechs have come good? I can't think of any offhand and I've been in a few! Yes, you can make money if you're good and lucky at trading in and out of these stocks, but long term? Nah, the odds are stacked against.
I also wonder what's the extent of the upside if it does come good? Does anybody really think that any of these biotechs will 10 or 20-bag? Does that really happen in the UK? If the tech was a dead cert, don't you think it would've been snapped up by some US or other big pharma by now? A 50% or even 100% premium would likely bag them the entire company for peanuts. There are examples of big multi-baggers I mean Novacyt more than 50-bagged in short order, but with very good reason: a massive spike in sales due to covid which suddenly produced enormous amounts of cold hard cash. That won't be happening here, obvs.
Anyway, good luck Donny, I know you've loyally stood firm. P.S. I've also got skin in the game, not that it's worth much nowadays. We all want the best out of this. Suggest I'm being more realistic though.